Genetic study in pleural mesothelioma
Part of Cancer, Lungs & breathing clinical trials.
This study looks at the role of inherited genes in malignant pleural mesothelioma. It includes people recently diagnosed and healthy people who were exposed to asbestos. The goal is to better understand why some people get this cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of malignant pleural mesothelioma.
- You are 18 years old or older.
- You agree to take part in the study.
- Or, you are a healthy person who has been exposed to asbestos in the past and are 18 or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study explores whether certain inherited gene changes make people more likely to develop myeloproliferative neoplasms (MPNs). It is looking at patients who were diagnosed at a young age or have a family history of blood cancers, to better understand the genetic causes of these conditions.
This study collects and analyzes tumor samples from patients with malignant pleural mesothelioma (a cancer of the lung lining caused by asbestos exposure) to better understand the disease and find new treatment approaches. Researchers will examine your tumor at the molecular level to identify patterns that might help predict treatment outcomes.
This study looks at tumor and blood samples to understand the genetic makeup of certain cancers, which may help guide treatment decisions. It's for people with specific types of lung cancer, head and neck cancer, or mesothelioma who are about to start chemotherapy plus immunotherapy.
This study collects tissue samples (from the lining around the lung) from adults with malignant pleural mesothelioma. Researchers will use these samples to check whether certain test markers can predict how the disease may behave, which could guide treatment decisions in the future.
This research study collects tissue samples from people having surgery for pleural mesothelioma (a rare lung cancer) or other lung diseases. The samples are used to better understand the disease and improve future treatments.
This study collects tissue samples (biopsies) and health information to better understand malignant mesothelioma and certain related solid tumors that may produce a protein called mesothelin. It may help future research and treatments, and you can only join if your diagnosis is confirmed and it’s safe for you to have the tissue taken.
Hear when a new Mesothelioma, Malignant Pleural trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.